4-102503036-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003998.4(NFKB1):​c.-8+1248A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.603 in 152,016 control chromosomes in the GnomAD database, including 28,531 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.60 ( 28531 hom., cov: 32)

Consequence

NFKB1
NM_003998.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.804

Publications

33 publications found
Variant links:
Genes affected
NFKB1 (HGNC:7794): (nuclear factor kappa B subunit 1) This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]
NFKB1 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 12
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.748 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003998.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFKB1
NM_003998.4
MANE Select
c.-8+1248A>G
intron
N/ANP_003989.2
NFKB1
NM_001382625.1
c.-78+864A>G
intron
N/ANP_001369554.1
NFKB1
NM_001382626.1
c.-78+1248A>G
intron
N/ANP_001369555.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFKB1
ENST00000226574.9
TSL:1 MANE Select
c.-8+1248A>G
intron
N/AENSP00000226574.4
NFKB1
ENST00000394820.8
TSL:1
c.-8+1248A>G
intron
N/AENSP00000378297.4
NFKB1
ENST00000505458.5
TSL:1
c.-8+869A>G
intron
N/AENSP00000424790.1

Frequencies

GnomAD3 genomes
AF:
0.603
AC:
91634
AN:
151896
Hom.:
28480
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.755
Gnomad AMI
AF:
0.591
Gnomad AMR
AF:
0.603
Gnomad ASJ
AF:
0.513
Gnomad EAS
AF:
0.463
Gnomad SAS
AF:
0.511
Gnomad FIN
AF:
0.532
Gnomad MID
AF:
0.611
Gnomad NFE
AF:
0.545
Gnomad OTH
AF:
0.583
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.603
AC:
91736
AN:
152016
Hom.:
28531
Cov.:
32
AF XY:
0.602
AC XY:
44724
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.755
AC:
31345
AN:
41492
American (AMR)
AF:
0.604
AC:
9230
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.513
AC:
1780
AN:
3470
East Asian (EAS)
AF:
0.463
AC:
2392
AN:
5168
South Asian (SAS)
AF:
0.510
AC:
2460
AN:
4824
European-Finnish (FIN)
AF:
0.532
AC:
5604
AN:
10530
Middle Eastern (MID)
AF:
0.612
AC:
180
AN:
294
European-Non Finnish (NFE)
AF:
0.545
AC:
36994
AN:
67938
Other (OTH)
AF:
0.577
AC:
1216
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1798
3596
5393
7191
8989
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
746
1492
2238
2984
3730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.582
Hom.:
3466
Bravo
AF:
0.615
Asia WGS
AF:
0.487
AC:
1682
AN:
3456

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
6.6
DANN
Benign
0.35
PhyloP100
0.80
PromoterAI
0.024
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3774932; hg19: chr4-103424193; API